RUA Life Sciences PLC Result of AGM (2528K)

TIDMRUA

RNS Number : 2528K

RUA Life Sciences PLC

23 August 2023

RUA Life Sciences plc

("RUA" the "Company" or the "Group")

Result of AGM

RUA Life Sciences plc (AIM:RUA.L), the holding company of a group of medical device businesses focussed on the exploitation of the world's leading long-term implantable biostable polymer (Elast-Eon (TM)), announces that all resolutions put forward to its Annual General Meeting held earlier today were duly passed and the votes cast were as follows:

 
 Res        Votes                Votes                Votes                  Votes 
  No.         For         %    Against        %       Total   % I.S.C.    Withheld 
 1      3,120,357   100.00%          0    0.00%   3,120,357      14.07           0 
       ----------  --------  ---------  -------  ----------  ---------  ---------- 
 2      2,229,757    71.48%    889,792   28.52%   3,119,549      14.06         808 
       ----------  --------  ---------  -------  ----------  ---------  ---------- 
 3      2,955,917    95.24%    147,790    4.76%   3,103,707      13.99      16,650 
       ----------  --------  ---------  -------  ----------  ---------  ---------- 
 4      2,951,476    95.23%    147,790    4.77%   3,099,266      13.97      21,091 
       ----------  --------  ---------  -------  ----------  ---------  ---------- 
 5      3,093,484    99.67%     10,223    0.33%   3,103,707      13.99      16,650 
       ----------  --------  ---------  -------  ----------  ---------  ---------- 
 6      2,980,778    95.53%    139,356    4.47%   3,120,134      14.06         223 
       ----------  --------  ---------  -------  ----------  ---------  ---------- 
 7      2,980,448    95.53%    139,569    4.47%   3,120,017      14.06         340 
       ----------  --------  ---------  -------  ----------  ---------  ---------- 
 8      2,951,597    95.48%    139,569    4.52%   3,091,166      13.93      29,191 
       ----------  --------  ---------  -------  ----------  ---------  ----------

The full text of each of the resolutions is set out in the notice of Annual General Meeting, copies of which are available on the Company's website (www.rualifesciences.com).

QCA Code - statement regarding voting result

The board notes that although Resolution 2 (remuneration committee report) passed with the requisite majority, it received more than 20% of votes against the board's recommendation. We thank shareholders for their support and the Board will look to continue engagement throughout the year. The board encourages an open and constructive dialogue directly with shareholders and continue to be willing to engage with any shareholder on any relevant topics should they so wish.

For further information contact:

RUA Life Sciences

Bill Brown, Chairman Tel: +44 (0)1294 317073

   Dr Caroline Stretton, Group MD                                             Tel: +44 (0)1294 317073 
   Cenkos Securities plc (Nominated Adviser and Broker)   Tel: +44 (0)20 7397 8900

Giles Balleny / Max Gould (Corporate Finance)

Michael Johnson (Sales)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGPJMATMTBTBAJ

(END) Dow Jones Newswires

August 23, 2023 11:18 ET (15:18 GMT)

Rua Life Sciences (LSE:RUA)
過去株価チャート
から 4 2024 まで 5 2024